-
Products
-
Professional
Pharmaceuticals
-
- Find a Physician
- Build Your Regimen
- Our Philosophy
- Press & Media
![]() Press & MediaSkinMedica Launches New Ablative Post-Procedure KitTreats and prolongs effects of CO2 and fractionated CO2 laser treatments Carlsbad, Calif. - October 15, 2009 - SkinMedica, Inc. launches a new Ablative Post-Procedure Kit which helps to cleanse, protect, heal, and preserve the skin following CO2 and fractionated CO2 laser treatments with the following SkinMedica products: NEW SkinMedica Restorative Ointment SkinMedica Sensitive Skin Cleanser SkinMedica TNS Ceramide Treatment Cream SkinMedica Environmental Defense Sunscreen SPF 30+ SkinMedica TNS Recovery Complex is additionally recommended to complement a post-procedure regimen and prolong laser results. This anti-aging gel contains the signature SkinMedica NouriCel-MD blend to enhance skin texture, reduce the appearance of age spots and blotchiness, and improve elasticity.
CLINICAL STUDY: A recent 21-day clinical study of female and male subjects, aged 28-69 years, comparing the efficacy and tolerability of Restorative Ointment versus a standard ointment in subjects who have received an ablative laser procedure discovered the following results:
SkinMedica Ablative Post-Procedure Kit will launch in October 2009 and will be available nationwide at doctor’s offices and medically supervised spas. Visit www.skinmedica.com for locations. CONTACT INFORMATION: ### About SkinMedica SkinMedica, Inc. is focused on developing, acquiring and commercializing products that treat dermatologic conditions and improve the appearance of skin. We market and sell to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products. The company's full line of aesthetic skin care products includes the revolutionary TNS Essential Serum™ and hallmark TNS Recovery Complex®. The formulations in our clinical skin care collection enhance skin appearance, reduce signs of aging and provide other skin care benefits. SkinMedica's prescription products include VANIQA® (eflornithine hydrochloride) Cream, 13.9%, the only FDA-approved prescription product for the reduction of unwanted facial hair in women and EpiQui® Micro Cream (4% hydroquinone) for hyperpigmentation, or "brown spots" that commonly result from aging, inflammation or sun exposure. SkinMedica is based in Carlsbad, California. For more information, visit: www.skinmedica.com. TNS Recovery Complex®, VANIQA®, EpiQuin® Micro, and SkinMedica®, are registered trademarks of SkinMedica, Inc and affiliates. |
||
|
|
||
|
Copyright © 2010 SkinMedica, Inc. and affiliates. All rights reserved.
|